United States: Health Care Fraud And Abuse In The Middle District Of Florida In 2016 - A Year In Review

Last Updated: March 4 2017
Article by Edward J. Page

The United States Attorney's Office (USAO) for the Middle District of Florida (USAO-MDFL) prosecuted several civil health care fraud matters in 2016 and issued related press releases. A review of the USAO-MDFL's criminal and civil health care fraud matters, as detailed in 24 of its 2016 press releases, helps predict where the USAO-MDFL will focus its health care enforcement efforts this year and beyond. This article organizes the USAO-MDFL's 2016 health care fraud matters by category and topic and offers pointers for health care providers within the USAO-MDFL's jurisdiction and elsewhere as we move into 2017.

Background

The USA0-MDFL has various tools to combat health care fraud, and used many of them in 2016. They include: (1) federal criminal prosecutions with prison, fines, and asset forfeiture; (2) False Claims Act civil actions that result in civil settlements but which can also lead to criminal investigations and related criminal prosecutions; (3) debarment, which keeps health care providers from providing health care services under various federal health care benefit programs; (4) pure asset forfeiture; (5) search warrants; (6) seizure warrants for bank accounts that hold funds derived from the alleged health care fraud; and, (7) suspension authority in the Affordable Care Act, which excludes health care providers from participating in the Medicare reimbursement program.

Companies and Individuals Targeted

In 2016, the USAO-MDFL brought criminal and civil cases against both companies and individuals. It focused on durable medical equipment providers; pharmacies; hospitals; home health care providers; medical clinics that billed for radiology, audiology, cardiology, and neurology services; a radiation oncology provider; unlicensed chiropractic clinics; infusion clinics; telemarketing call centers; urgent medical care clinics; prescription compounding pharmacies; physicians groups; skilled nursing facilities; a cancer treatment clinic; an orthopedic medical group; and a pharmaceutical company. 

It also took action against individual cardiologists, pain management physicians, general practice physicians, neurologists, home health care owners, a medical director, health care clinic physicians, persons who allegedly served as sham medical directors conducting quality reviews of patient charts, chiropractors, registered nurses, licensed pharmacists, physician's assistants, business owners, infusion clinic owners, individuals no longer on Social Security Disability or who became ineligible and continued to receive such disability payments, urgent care medical doctors, licensed osteopathic doctors, an owner of a skilled nursing facility, and others.

While it appears the USAO-MDFL did not single out a lawyer for attention in 2016, it has in the recent past. The USAO-MDFL's scrutiny of individuals is consistent with the U.S. Department of Justice's September 9, 2015 Yates Memo, which emphasized that justice must be meted out to both the corporation involved in the fraud and abuse and the "individuals who perpetrated the wrongdoing."

The USAO-MDFL does not focus on particular health care practices, specialties, or industries, but rather on the underlying facts uncovered in investigations to determine if health care fraud and abuse exists. This is why such a broad range of businesses and individuals are involved in the matters noted in the USAO-MDFL's's 2016 press releases.

Federal Health Care Programs Involved

in 2016, as in past years, the USAO-MDFL prosecuted health care fraud and abuse matters that impacted Medicare, Medicaid, TRICARE (the U.S. military health care program), and the Federal Employees Health Benefits Program. 

The USAO-MDFL does not focus on a particular health care benefit program. The health care matters mentioned in the 2016 USAO-MDFL press releases were distributed among the major federal health care programs.

Federal Statutes Allegedly Violated

Numerous statutes are used to prosecute individuals and companies for health care fraud. False statements submitted to the government for Medicare payments may be prosecuted under the false statement statute, the false claims statute, or the mail fraud statute. For kickbacks, the government may also proceed under 18 Title 42 U.S.C. Section 1320a-7b(b), which outlaws any payment for a referral of a Medicare patient. Finally, 18 U.S.C Section 1347 makes it a crime to engage in a scheme to defraud any health care benefit program. These are just some of the federal statutes in the USAO-MDFL's toolbox.

While the USAO-MDFL must prove the elements of any statutes beyond a reasonable doubt, it is rarely difficult to do so in "fraud at the outset" cases (where fraud is planned at the outset). It is more challenging in the "optimization" type matter, which seeks to discern bad or criminal intent from billing practices or other business methods that may or may not withstand scrutiny.

Numerous Federal Investigators Handled the 2016 Matters

Many federal agencies have the authority to investigate health care fraud matters. Those that did so in 2016 included the FBI, Health and Human Services Office of the Inspector General (HHS-OIG), Defense Criminal Investigative Services, Veterans Affairs Office, Office of Personnel Management, Florida's Department of Financial Services Division, the Internal Revenue Service, and the Social Security Office of the Inspector General.

The USAO-MDFL Team Approach

In past years, the USAO-MDFL organized into teams to bring civil and criminal prosecutions. These teams include Health Care Fraud Prevention and Enforcement, Medicare Fraud Task Force, and the National Health Care Fraud Initiative.

How the USAO-MDFL Detected Alleged Health Care Fraud

Detection methods included: voluntary disclosure by the company engaged in the alleged fraud; former employees (False Claim Act "relators") who reported the fraud to the USAO- MDFL; tipsters; and outlier analysis by Medicare (the "proactive review of claims data" that revealed the provider "was a statistical outlier in terms of billing for" the services for which they billed Medicare). 

Financial Rewards for Relators/Tipsters

Former employees who reported alleged fraud included a medical doctor, a physicist, and a former medical assistant. Their rewards ranged from $37,500 to $29 million. Of the 24 health care fraud matters for which the USAO-MDFL issued 2016 press releases, it appears that about five relators were involved. A relator is simply someone who brings a lawsuit against a defendant in the government's name.

How Cases Were Resolved

Resolution methods included criminal jury trial, civil settlement, guilty pleas, voluntary exclusion from federal health care programs, and corporate integrity agreements.

Health Care Fraud Theories

Fraud cases were based on:

  • products not provided;
  • services not rendered;
  • procedures not medically necessary;
  • bonuses for physicians who ordered unnecessary tests;
  • unlicensed chiropractic clinic services;
  • false billings;
  • kickbacks to patients by waiving the 20 percent Medicare copayment without regard to the patient's financial hardship;
  • excessive and medically unnecessary and inadequately documented peripheral artery interventional services;
  • medications represented to contain pharmaceutical ingredients that did not;
  • bonuses paid to a urologist for referring laboratory tests to a lab;
  • providing a Medicare provider number to a chiropractor who billed Medicare for services rendered;
  • payments to Medicare patients to see physicians who prescribed expensive medications;
  • prescriptions that were "tainted" under the anti-kickback statute because the physician who prescribed them had an alleged ownership interest in the pharmacy that filled them;
  • billing Medicare and TRICARE for rehabilitation therapy services that were not reasonable, necessary, or skilled;
  • administration of misbranded drugs to patients and billing Medicare for them as if they were FDA-approved; and,
  • certain suspect billing practices that when reviewed together indicate an intent to bill for medically unnecessary services.

False Claims Act Cases that Became Federal Criminal Cases

It appears from USAO-MDFL press releases that about five of the matters that started as federal False Claims Act civil cases developed into federal criminal cases. At least one developed after the U.S. Department of Justice (DOJ) evaluated the provider's claim data and concluded the provider was a statistical "outlier." In that case, the USAO-MDFL press release noted that "New and expanded uses of data analytics to identify suspicious billing patterns ... are providing law enforcement with powerful investigative tools ...." Other cases appear to have started as criminal cases without regard to the False Claims Act.

Pointers for USAO-MDFL Health Care Providers

The 24 health care matters mentioned in 2016 USAO-MDFL press releases are of the usual two types. The first type is health care fraud planned from the outset as a fraud. More than half of the 24 matters reviewed appear to involve allegations of such "fraud at the outset." They include providing medically unnecessary services, and Stark law violations. The government may be unable to prove "fraud at the outset" type cases, but with its powerful tools, as long as enough witnesses come forward, and they often do, albeit slowly, it's often easy to prove the fraud with the available documents submitted to Medicare, TRICARE, or another federal health care program.

The second type of health care fraud matter is the more difficult to spot and prosecute business type. In these cases, the health care provider enacts a policy or business practice that ultimately proves unsound and problematic. For example, in the orthopedic surgery practice case the USAO-MDFL recently settled, seven alleged suspect billing practices were involved, all of which appeared to optimize Medicare billings. It's one thing to have one questionable billing practice, but it's another entirely to have seven such practices scrutinized by the MDFL. These become clues. The more clues the USAO-MDFL discovers, the more easily it can make a case, demand a settlement, and impose other conditions.

A few of the 24 matters reviewed could be described as "send a message prosecutions," or national initiatives that result in many simultaneously-filed charges against the same type of alleged violators around the country. The USAO-MDFL and others that enforce the federal statutes realize they can't prosecute all violators, but they can prosecute many and make a lot of noise about it in an effort to deter others from the committing the same violations. These initiatives sometimes stem from published HHS-OIG and DOJ initiatives and priorities.

Claims data submitted to Medicare or its contractor can show if the provider is an outlier, which may prompt an official inquiry by the agencies mentioned above. It's wise to be careful with any "systematic effort to increase ... Medicare and TRICARE billings." Given that individualized health care dominates our health care system, making patients' clinical needs paramount, systematic efforts don't fit well.

Intent is critical in health care fraud as it is in most white collar criminal prosecutions. The USAO-MDFL looks for evidence of bad intent in its health care fraud matters. And it often finds it in emails, text messages, voicemail messages, memos, diaries, notes to self, cheat sheets, and also in the provider's billing practices. It's one thing to inappropriately code and bill for claims "incident" to physician supervision when no physician was present, but when that is combined with a variety of other suspect billing practices, it's easier for the USAO-MDFL to ask hard questions and judge intent.

Compliance programs, which pay for themselves, must be implemented and followed — though they are ineffective in "fraud at the outset" matters. 

The USAO-MDFL's health care fraud and abuse investigations create risk for individuals and companies. It's best to confront the risk when it's detected rather than engage in denial or rationalization. Health care executives must make difficult decisions — e.g., whether to self-report, fight the subpoena, or cooperate. Each decision must contemplate the particular facts uncovered in a defense lawyer's investigation and inquiry into the allegations.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions